Genetic signatures of HIV-1 envelope-mediated bystander apoptosis

Journal of Biological Chemistry

Volumn 289, Issue 5, 2014, Pages 2497-2514

  Joshi, Anjali ^a   Lee, Raphael T C ^b,c   Mohl, Jonathan ^a   Sedano, Melina ^a   Khong, Wei Xin ^c   Ng, Oon Tek ^c   Maurer Stroh, Sebastian ^b,d   Garg, Himanshu ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS; APOPTOSIS; GENETICS; HIV; INFECTIOUS DISEASES; RETROVIRUS; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BYSTANDER EFFECT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HELA CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; PHENOTYPE; PHYLOGENY; RECEPTORS, CCR5;

EID: 84893510188     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.514018     Document Type: Article

References (91)

1. + T cells by a Fas-independent mechanism. J. Exp. Med. 187, 1113-1122
2. Garg, H., Mohl, J., and Joshi, A. (2012) HIV-1 induced bystander apoptosis. Viruses 4, 3020-3043
3. Douek, D. (2007) HIV disease progression. Immune activation, microbes, and a leaky gut. Top. HIV Med. 15, 114-117
4. + T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J. Virol. 83, 572-583
5. Van Gils, M. J., Edo-Matas, D., Bowles, E. J., Burger, J. A., Stewart-Jones, G. B., and Schuitemaker, H. (2011) Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum. J. Virol. 85, 8443-8448
6. Gougeon, M. L., and Montagnier, L. (1993) Apoptosis in AIDS. Science 260, 1269-1270
7. Oyaizu, N., McCloskey, T. W., Than, S., Hu, R., and Pahwa, S. (1995) Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. Adv. Exp. Med. Biol. 374, 101-114
8. Oyaizu, N., McCloskey, T. W., Coronesi, M., Chirmule, N., Kalyanaraman, V. S., and Pahwa, S. (1993) Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82, 3392-3400
9. Finkel, T. H, Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C, Baba, T. W., Ruprecht, R. M., and Kupfer, A. (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1, 129-134
10. Meythaler, M., Pryputniewicz, S., and Kaur, A. (2008) Kinetics of T lymphocyte apoptosis and the cellular immune response in SIVmac239-infected rhesus macaques. J. Med. Primatol. 37, 33-45
11. Garg, H, Joshi, A., Ye, C, Shankar, P., and Manjunath, N. (2011) Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice. Virol. J. 8, 34
12. Perfettini, J. L., Castedo, M., Roumier, T., Andreau, K., Nardacci, R., Piacentini, M., and Kroemer, G. (2005) Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ. 12, 916-923
13. Ahr, B., Robert-Hebmann, V., Devaux, C, and Biard-Piechaczyk, M. (2004) Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology 1, 12
14. Shankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H, He, X., Huang, X. L., and Mullins, J. I. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73, 10489-10502
15. Edo-Matas, D., Rachinger, A., Setiawan, L. C, Boeser-Nunnink, B. D., Van't Wout, A. B., Lemey, P., and Schuitemaker, H. (2012) The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donorrecipient pair. Virology 422, 70-80
16. Navis, M., Matas, D. E., Rachinger, A., Koning, F. A., Van Swieten, P., Kootstra, N. A., and Schuitemaker, H. (2008) Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs. PLoS One 3, e2422
17. Hahn, B. H., Gonda, M. A., Shaw, G. M., Popovic, M., Hoxie, J. A., Gallo, R. C, and Wong-Staal, F. (1985) Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III. Different viruses exhibit greatest divergence in their envelope genes. Proc. Natl. Acad. Sci. U. S. A. 82, 4813-4817
18. Curlin, M. E., Zioni, R., Hawes, S. E., Liu, Y., Deng, W., Gottlieb, G. S., Zhu, T., and Mullins, J. I. (2010) HIV-1 envelope subregion length variation during disease progression. PLoS Pathog. 6, e1001228
19. Shankarappa, R., Gupta, P., Learn, G. H., Jr., Rodrigo, A. G., Rinaldo, C. R., Jr., Gorry, M. C, Mullins, J. I., Nara, P. L., and Ehrlich, G. D. (1998) Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology 241, 251-259
20. Gray, L., Roche, M., Churchill, M. J., Sterjovski, J., Ellett, A., Poumbourios, P., Sherieff, S., Wang, B., Saksena, N., Purcell, D. F., Wesselingh, S., Cunningham, A. L., Brew, B. J., Gabuzda, D., and Gorry, P. R. (2009) Tissuespecific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain. J. Virol. 83, 5430-5441
21. Schuitemaker, H., Van 't Wout, A. B., and Lusso, P. (2011) Clinical significance of HIV-1 coreceptor usage. J. Transl. Med. 9, S5
22. Edo-Matas, D., Van Dort, K. A., Setiawan, L. C, Schuitemaker, H., and Kootstra, N. A. (2011) Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants. Virology 412, 269-277
23. Schuitemaker, H, Koot, M., Kootstra, N. A., Dercksen, M. W., De Goede, R. E., Van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F., and Tersmette, M. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection. Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354-1360
24. Jansson, M., Backstrom, E., Bjorndal, A., Holmberg, V., Rossi, P., Fenyo, E. M., Popovic, M., Albert, J., and Wigzell, H. (1999) Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS. J. Hum. Virol. 2, 325-338
25. Esbjornsson, J., Månsson, F., Martínez-Arias, W., Vincic, E., Biague, A. J., Da Silva, Z. J., Fenyo, E. M., Norrgren, H, and Medstrand, P. (2010) Frequent CXCR4 tropism of HIV-1 subtype A and CRF02-AG during latestage disease. Indication of an evolving epidemic in West Africa. Retrovirology 7, 23
26. Olivieri, K., Scoggins, R. M., Bor, Y. C, Matthews, A., Mark, D., Taylor, J. R., Jr., Chernauskas, D., Hammarskjold, M. L., Rekosh, D., and Camerini, D. (2007) The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. Virology 358, 23-38
27. + cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection. Virology 396, 246-255
28. Bjorndal, A., Sonnerborg, A., Tscherning, C, Albert, J., and Fenyo, E. M. (1999) Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res. Hum. Retroviruses 15, 647-653
29. McDermott, A. B., and Koup, R. A. (2012) CD8+ T cells in preventing HIV infection and disease. AIDS 26, 1281-1292
30. Streeck, H., and Nixon, D. F. (2010) T cell immunity in acute HIV-1 infection. J. Infect. Dis. 202, S302-S308
31. Mosier, D. E. (2005) HIV-1 envelope evolution and vaccine efficacy. Curr. Drug Targets Infect. Disord. 5, 171-177
32. Borggren, M., Repits, J., Sterjovski, J., Uchtenhagen, H., Churchill, M. J., Karlsson, A., Albert, J., Achour, A., Gorry, P. R., Fenyo, E. M., and Jansson, M. (2011) Increased sensitivity to broadly neutralizing antibodies of endstage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge. PLoS One 6, e20135
33. Sagar, M., Wu, X., Lee, S., and Overbaugh, J. (2006) Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J. Virol. 80, 9586-9598
34. Van Gils, M. J., Bunnik, E. M., Boeser-Nunnink, B. D., Burger, J. A., Terlouw-Klein, M., Verwer, N., and Schuitemaker, H. (2011) Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies. J. Virol. 85, 6986-6995
35. Wei, X., Decker, J. M., Wang, S., Hui, H, Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., Komarova, N. L., Nowak, M. A., Hahn, B. H., Kwong, P. D., and Shaw, G. M. (2003) Antibody neutralization and escape by HIV-1. Nature 422, 307-312
36. Li, S., Juarez, J., Alali, M., Dwyer, D., Collman, R., Cunningham, A., and Naif, H. M. (1999) Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73, 9741-9755
37. Gray, L., Sterjovski, J., Churchill, M., Ellery, P., Nasr, N., Lewin, S. R., Crowe, S. M., Wesselingh, S. L., Cunningham, A. L., and Gorry, P. R. (2005) Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337, 384-398
38. Thomas, E. R., Dunfee, R. L., Stanton, J., Bogdan, D., Taylor, J., Kunstman, K., Bell, J. E., Wolinsky, S. M., and Gabuzda, D. (2007) Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 360, 105-119
39. Sterjovski, J., Churchill, M. J., Roche, M., Ellett, A., Farrugia, W., Wesselingh, S. L., Cunningham, A. L., Ramsland, P. A., and Gorry, P. R. (2011) CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity. Virology 410, 418-428
40. Garg, H., Joshi, A., Freed, E. O., and Blumenthal, R. (2007) Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J. Biol. Chem. 282, 16899-16906
41. Garg, H, and Blumenthal, R. (2006) HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir. J. Leukoc. Biol. 79, 351-362
42. Meissner, E. G., Coffield, V. M., and Su, L. (2005) Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology 336, 184-197
43. Meissner, E. G., Duus, K. M., Gao, F., Yu, X. F., and Su, L. (2004) Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor. Role of the envelope. Virology 328, 74-88
44. Joshi, A., Nyakeriga, A. M., Ravi, R., and Garg, H. (2011) HIV ENV glycoprotein-mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity. J. Biol. Chem. 286, 36404-36413
45. Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., and Kabat, D. (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates ofhuman immunodeficiency virus type 1. J. Virol. 72, 2855-2864
46. Kulkarni, S. S., Lapedes, A., Tang, H., Gnanakaran, S., Daniels, M. G., Zhang, M., Bhattacharya, T., Li, M., Polonis, V. R., McCutchan, F. E., Morris, L., Ellenberger, D., Butera, S. T., Bollinger, R. C., Korber, B. T., Paranjape, R. S., and Montefiori, D. C. (2009) Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India. Virology 385, 505-520
47. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., Bilska, M., Kothe, D. L., Salazar-Gonzalez, J. F., Wei, X., Decker, J. M., Hahn, B. H., and Montefiori, D. C. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125
48. Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., and Kappes, J. C. (2002) Emergenceof resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896-1905
49. Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., Shaw, G. M., Korber, B. T., Allen, S., and Hunter, E. (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303, 2019-2022
50. Williamson, C., Morris, L., Maughan, M. F., Ping, L. H., Dryga, S. A., Thomas, R., Reap, E. A., Cilliers, T., Van Harmelen, J., Pascual, A., Ramjee, G., Gray, G., Johnston, R., Karim, S. A., and Swanstrom, R. (2003) Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res. Hum. Retroviruses 19, 133-144
51. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011) MEGA5. Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739
52. Huang, C. C., Lam, S. N., Acharya, P., Tang, M., Xiang, S. H., Hussan, S. S., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., Wyatt, R., Bewley, C. A., and Kwong, P. D. (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317, 1930-1934
53. Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., Wyatt, R., and Kwong, P. D. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310, 1025-1028
54. McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J. P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., O'Dell, S., Patel, N., Shahzadul-Hussan, S., Yang, Y., Zhang, B., Zhou, T., Zhu, J., Boyington, J. C., Chuang, G. Y., Diwanji, D., Georgiev, I., Kwon, Y. D., Lee, D., Louder, M. K., Moquin, S., Schmidt, S. D., Yang, Z. Y., Bonsignori, M., Crump, J. A., Kapiga, S. H., Sam, N. E., Haynes, B. F., Burton, D. R., Koff, W. C., Walker, L. M., Phogat, S., Wyatt, R., Orwenyo, J., Wang, L. X., Arthos, J., Bewley, C. A., Mascola, J. R., Nabel, G. J., Schief, W. R., Ward, A. B., Wilson, I. A., and Kwong, P. D. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480, 336-343
55. Krieger, E., Koraimann, G., and Vriend, G. (2002) Increasing the precision of comparative models with YASARA NOVA. A self-parameterizing force field. Proteins 47, 393-402
56. Eswar, N., Eramian, D., Webb, B., Shen, M. Y., and Sali, A. (2008) Protein structure modeling with MODELLER. Methods Mol. Biol. 426, 145-159
57. Li, H., Robertson, A. D., and Jensen, J. H. (2005) Very fast empirical prediction and rationalization of protein pKa values. Proteins 61, 704-721
58. Katoh, K., Kuma, K., Toh, H., and Miyata, T. (2005) MAFFT version 5. Improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 33, 511-518
59. Blanco, J., Barretina, J., Ferri, K. F., Jacotot, E., Gutiérrez, A., Armand-Ugón, M., Cabrera, C., Kroemer, G., Clotet, B., and Esté, J. A. (2003) Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. Virology 305, 318-329
60. Biard-Piechaczyk, M., Robert-Hebmann, V., Richard, V., Roland, J., Hipskind, R. A., and Devaux, C. (2000) Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology 268, 329-344
61. Garg, H., Joshi, A., and Blumenthal, R. (2009) Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants. AIDS Res. Hum. Retroviruses 25, 811-817
62. Gnanakaran, S., Daniels, M. G., Bhattacharya, T., Lapedes, A. S., Sethi, A., Li, M., Tang, H., Greene, K., Gao, H., Haynes, B. F., Cohen, M. S., Shaw, G. M., Seaman, M. S., Kumar, A., Gao, F., Montefiori, D. C., and Korber, B. (2010) Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput. Biol. 6, e1000955
63. Rong, R., Li, B., Lynch, R. M., Haaland, R. E., Murphy, M. K., Mulenga, J., Allen, S. A., Pinter, A., Shaw, G. M., Hunter, E., Robinson, J. E., Gnanakaran, S., and Derdeyn, C. A. (2009) Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog. 5, e1000594
64. De Mendoza, C., Van Baelen, K., Poveda, E., Rondelez, E., Zahonero, N, Stuyver, L., Garrido, C., Villacian, J., and Soriano, V. (2008) Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters. J. Acquir. Immune Defic. Syndr. 48, 241-244
65. Xu, S., Huang, X., Xu, H, and Zhang, C. (2007) Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J. Microbiol. 45, 441-446
66. Sterjovski, J., Churchill, M. J., Ellett, A., Gray, L. R., Roche, M. J., Dunfee, R. L., Purcell, D. F., Saksena, N, Wang, B., Sonza, S., Wesselingh, S. L., Karlsson, I., Fenyo, E. M., Gabuzda, D., Cunningham, A. L., and Gorry, P. R. (2007) Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology 4, 89
67. Pirovano, W., Feenstra, K. A., and Heringa, J. (2006) Sequence comparison by sequence harmony identifies subtype-specific functional sites. Nucleic Acids Res. 34, 6540-6548
68. Garg, H, and Blumenthal, R. (2008) Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis. CellMol. Life Sci. 65, 3134-3144
69. Denizot, M., Varbanov, M., Espert, L., Robert-Hebmann, V., Sagnier, S., Garcia, E., Curriu, M., Mamoun, R., Blanco, J., and Biard-Piechaczyk, M. (2008) HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 4, 998-1008
70. Finkel, T. H., and Banda, N. K. (1994) Indirect mechanisms of HIV pathogenesis. How does HIV kill T cells? Curr. Opin. Immunol. 6, 605-615
71. Castedo, M., Perfettini, J. L., Andreau, K., Roumier, T., Piacentini, M., and Kroemer, G. (2003) Mitochondrial apoptosis induced by the HIV-1 envelope. Ann. N. Y. Acad. Sci. 1010, 19-28
72. Varbanov, M., Espert, L., and Biard-Piechaczyk, M. (2006) Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins. AIDS Rev. 8, 221-236
73. + T lymphocyte destruction by HIV-1. Autophagy 3, 32-34
74. Gordon, S. N, Dunham, R. M., Engram, J. C, Estes, J., Wang, Z., Klatt, N. R, Paiardini, M., Pandrea, I. V, Apetrei, C, Sodora, D. L, Lee, H. Y., Haase, A. T., Miller, M. D., Kaur, A., Staprans, S. I, Perelson, A. S., Feinberg, M. B, and Silvestri, G. (2008) Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus. Implications for AIDS pathogenesis. J. Virol. 82, 3725-3735
75. Gougeon, M. L., Colizzi, V., Dalgleish, A., and Montagnier, L. (1993) New concepts in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 9, 287-289
76. + target cells. Res. Virol. 146, 5-17
77. Bunnik, E. M., Lobbrecht, M. S., Van Nuenen, A. C, and Schuitemaker, H. (2010) Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity. Virology 397, 224-230
78. Holm, G. H, Zhang, C, Gorry, P. R., Peden, K., Schols, D., De Clercq, E., and Gabuzda, D. (2004) Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure. J. Virol. 78, 4541-4551
79. Meissner, E. G., Zhang, L., Jiang, S., and Su, L. (2006) Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus. J. Virol. 80, 11019-11030
80. Koot, M., Van 't Wout, A. B., Kootstra, N. A., De Goede, R. E., Tersmette, M., and Schuitemaker, H. (1996) Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 173, 349-354
81. Spijkerman, I., De Wolf, F., Langendam, M., Schuitemaker, H, and Coutinho, R. (1998) Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS. J. Infect. Dis. 178, 397-403
82. Van Rij RP, Blaak, H., Visser, J. A., Brouwer, M., Rientsma, R., Broersen, S., De Roda Husman AM, and Schuitemaker, H. (2000) Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J. Clin. Invest. 106, 1569
83. Kaneshima, H., Su, L., Bonyhadi, M. L., Connor, R. I., Ho, D. D., and McCune, J. M. (1994) Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J. Virol. 68, 8188-8192
84. + T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J. Exp. Med. 188, 1159-1171
85. Cayabyab, M., Karlsson, G. B., Etemad-Moghadam, B. A., Hofmann, W., Steenbeke, T., Halloran, M., Fanton, J. W., Axthelm, M. K., Letvin, N. L., and Sodroski, J. G. (1999) Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J. Virol. 73, 976-984
86. La Bonte, J. A., Patel, T., Hofmann, W., and Sodroski, J. (2000) Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J. Virol. 74, 10690-10698
87. Etemad-Moghadam, B., Sun, Y., Nicholson, E. K., Fernandes, M., Liou, K., Gomila, R., Lee, J., and Sodroski, J. (2000) Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo. J. Virol. 74, 4433-4440
88. Etemad-Moghadam, B., Rhone, D., Steenbeke, T., Sun, Y., Manola, J., Gelman, R., Fanton, J. W., Racz, P., Tenner-Racz, K., Axthelm, M. K., Letvin, N. L., and Sodroski, J. (2001) Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J. Virol. 75, 5646-5655
89. + T-cell recovery. A randomized trial. Blood 121, 4635-4646
90. Holman, A. G., and Gabuzda, D. (2012) A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia. PLoS One 7, e49538
91. Holman, A. G., Mefford, M. E., O'Connor, N, and Gabuzda, D. (2010) HIV Brain Seq DB. A database of annotated HIV envelope sequences from brain and other anatomical sites. AIDS Res. Ther. 7, 43